Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation

This study has been completed.
Sponsor:
Collaborators:
Medical Research Council of Canada
Merck Sharp & Dohme Corp.
Pfizer
GE Healthcare
Bristol-Myers Squibb
Astellas Pharma Inc
AstraZeneca
Sanofi
Datascope Corp.
First Horizon
Kos
Key Pharmaceuticals
Integrated Therapeutics Group
Hoest-Marion-Roussel
Information provided by:
Department of Veterans Affairs
ClinicalTrials.gov Identifier:
NCT00007657
First received: December 29, 2000
Last updated: June 12, 2009
Last verified: June 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2006
  Estimated Primary Completion Date: No date given
No publications provided by Department of Veterans Affairs

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):